Tao Guo
222 Zhongshan Road
Dalian, 116011, China
Dalian, 116011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Robotic-assisted optical navigation system for CT-guided preoperative percutaneous Hook-wire localization of pulmonary nodules: a prospective, single-center, single-arm clinical study.
Journal: World journal of surgical oncology
Published: August 05, 2025
IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR-Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 18, 2025
MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4.
Journal: Cell death discovery
Published: August 07, 2024
SPTLC2 drives an EGFR-FAK-HBEGF signaling axis to promote ovarian cancer progression.
Journal: Oncogene
Published: May 03, 2024
MACC1 enhances an oncogenic RNA splicing of IRAK1 through interacting with HNRNPH1 in lung adenocarcinoma.
Journal: Journal of cellular physiology
Published: March 18, 2024
Genomic heterogeneity of multiple synchronous lung cancers in Chinese population.
Journal: Cancer medicine
Published: July 31, 2023
Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell Lung Cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis.
Journal: American journal of clinical oncology
Published: June 30, 2023
A New Risk Score Model Based on Pyrogenic Signatures for the Prediction of Survival and Immune Microenvironment Features in Lung Adenocarcinoma.
Journal: International journal of general medicine
Published: March 16, 2023
Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis.
Journal: Cell metabolism
Published: November 02, 2022
VLDLR disturbs quiescence of breast cancer stem cells in a ligand-independent function.
Journal: Frontiers in oncology
Published: March 01, 2022
Nuclear Aurora kinase A switches m6A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4.
Journal: Signal transduction and targeted therapy
Published: August 04, 2021
Last Updated: 09/26/2026